Persistent unexplained chest pain and dyspnea in a patient with coronary artery disease: a case report
- PMID: 32019498
- PMCID: PMC7001197
- DOI: 10.1186/s12872-020-01348-w
Persistent unexplained chest pain and dyspnea in a patient with coronary artery disease: a case report
Abstract
Background: Neurogenic orthostatic hypotension, a sustained decrease in blood pressure upon standing, is caused by autonomic nervous system failure and characterized by an insufficient increase in heart rate needed to maintain blood pressure upon standing. In this case, neurogenic orthostatic hypotension symptoms preceded a diagnosis of Parkinson disease. A diagnosis of underlying neurogenic orthostatic hypotension significantly changed the course of treatment for this patient.
Case presentation: An 84-year-old woman was referred to a cardiologist by her primary care practitioner for evaluation of exertional dyspnea and chest pain upon walking a few feet. Her medical history included hypertension, hypothyroidism, and osteoarthritis. Based on her continued symptoms, the patient underwent 2 cardiac catheterizations for coronary artery stenosis. After the catheterizations, exertional dyspnea and chest pain continued, and subsequently, dysphagia to solid foods and episodic dizziness developed. Orthostatic evaluation showed a supine blood pressure of 150/80 mmHg with a heart rate of 70 beats per min. Upon standing for 3 min, the patient's blood pressure decreased to 110/74 mmHg with a heart rate of 76 beats per min. The diagnostic criteria for orthostatic hypotension were met, and the lack of an adequate compensatory heart rate increase upon standing was consistent with a neurogenic cause (ie, neurogenic orthostatic hypotension), which was supported by tilt-table testing results. Although nonpharmacologic treatments were initially successful, episodes of lightheadedness, chest pain, and dyspnea upon standing became more frequent, and the patient was prescribed droxidopa (200 mg; 3 times daily). Droxidopa significantly improved her symptoms, with the patient reporting resolution of her chest pain and significant improvement of dyspnea and dizziness. She was diagnosed with Parkinson disease approximately 6 months later.
Conclusions: This case highlights the importance of evaluating and identifying potential causes of symptoms of cardiovascular disease when persistent symptoms do not improve after cardiac interventions. This case complements findings demonstrating that signs of autonomic failure, such as neurogenic orthostatic hypotension, may precede the motor symptoms of Parkinson disease. Importantly, this case provides real-world evidence for the efficacy of droxidopa to treat the symptoms of neurogenic orthostatic hypotension, after an appropriate diagnosis.
Keywords: Autonomic nervous system; Cardiac catheterization; Droxidopa; Neurogenic orthostatic hypotension; Parkinson disease.
Conflict of interest statement
SKM is a consultant and speaker for Lundbeck, Novartis, and Janssen.
Figures

Similar articles
-
Neurogenic orthostatic hypotension in Parkinson's disease: evaluation, management, and emerging role of droxidopa.Vasc Health Risk Manag. 2014 Apr 3;10:169-76. doi: 10.2147/VHRM.S53983. eCollection 2014. Vasc Health Risk Manag. 2014. PMID: 24729712 Free PMC article. Review.
-
Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa.Hypertension. 2015 Jan;65(1):101-7. doi: 10.1161/HYPERTENSIONAHA.114.04035. Epub 2014 Oct 27. Hypertension. 2015. PMID: 25350981 Free PMC article. Clinical Trial.
-
Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial.Neurology. 2014 Jul 22;83(4):328-35. doi: 10.1212/WNL.0000000000000615. Epub 2014 Jun 18. Neurology. 2014. PMID: 24944260 Free PMC article. Clinical Trial.
-
Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease (nOH306B).Mov Disord. 2015 Apr 15;30(5):646-54. doi: 10.1002/mds.26086. Epub 2014 Dec 9. Mov Disord. 2015. PMID: 25487613 Clinical Trial.
-
Diagnosing and treating neurogenic orthostatic hypotension in primary care.Postgrad Med. 2015;127(7):702-15. doi: 10.1080/00325481.2015.1050340. Epub 2015 May 27. Postgrad Med. 2015. PMID: 26012731 Review.
Cited by
-
Neurogenic Orthostatic Hypotension. Lessons From Synucleinopathies.Am J Hypertens. 2021 Mar 11;34(2):125-133. doi: 10.1093/ajh/hpaa131. Am J Hypertens. 2021. PMID: 33705537 Free PMC article. Review.
-
Massive Spontaneous Pneumomediastinum-A Form of Presentation for Severe COVID-19 Pneumonia.Medicina (Kaunas). 2022 Oct 26;58(11):1525. doi: 10.3390/medicina58111525. Medicina (Kaunas). 2022. PMID: 36363482 Free PMC article.
References
-
- Gibbons CH, Schmidt P, Biaggioni I, Frazier-Mills C, Freeman R, Isaacson S, et al. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol. 2017;264:1567–1582. doi: 10.1007/s00415-016-8375-x. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous